SHANGHAI, May 29, 2026 — The global medical device landscape is witnessing a distinct shift as public health sectors transition from standalone equipment procurement to full-chain emergency response solutions. Leading this paradigm shift is Jousing Medical (久心医疗), China’s pioneer in native defibrillation technology.
Newly released industry data reveals that Jousing Medical captured a massive 45.91% market share in volume, ranking number one across China in Q1 2026. This domestic dominance, paired with their milestone European Union Medical Device Regulation (EU MDR) certification, firmly establishes the brand as a global force in public access defibrillation (PAD).
1. Dominating the Home Market: Market Share Analysis
Jousing’s performance in the first quarter of 2026 highlights the accelerating consolidation of China’s automated external defibrillator market.
| Metric (Q1 2026) | Jousing Medical Performance | Industry Standing |
| National Market Share (Volume) | 45.91% | Ranked No. 1 Nationally |
| Domestic Installed Base | Approaching 100,000 Units | Market Leader |
| Clinical First-Shock Success Rate | Over 98% (Advanced Algorithm) | Industry Benchmark |
This high market concentration is driven by massive deployments across national public transit infrastructure, smart corporate campuses, and grassroots primary care networks, making Jousing the most trusted name in domestic emergency medical procurement.
2. Breaking Regulatory Barriers: EU MDR Certification Opens 30+ Global Markets
Securing the EU MDR certificate represents the gold standard of international compliance. Under the modern MDR framework, AEDs are classified under Rule 22 as Class III (highest-risk) devices, demanding incredibly rigorous technical documentation, clinical evaluations, and total quality management system audits.
Jousing Medical’s successful compliance breakthrough serves as an international passport. To date, Jousing’s life-saving technologies have successfully penetrated more than 30 countries. Real-world clinical success stories—including four recorded successful cardiac arrest resuscitations in Italy and official product excellence accolades from the Ministry of Public Health in Thailand—prove that Jousing’s clinical reliability translates perfectly across borders.
3. Beyond the Device: The “Device + Smart Platform + Training” Full-Chain Solution
Distributors and global healthcare ministries are increasingly rejecting isolated hardware procurement. To optimize survival rates during the “Golden 4 Minutes” of sudden cardiac arrest, Jousing Medical has pioneered an end-to-end emergency ecosystem.